ContraVir Pharmaceuticals (CTRV) Stock Price Down 6.8%
ContraVir Pharmaceuticals Inc (NASDAQ:CTRV)’s share price fell 6.8% during mid-day trading on Thursday . The stock traded as low as $0.38 and last traded at $0.41. 1,631,100 shares changed hands during mid-day trading, an increase of 75% from the average session volume of 934,181 shares. The stock had previously closed at $0.44.
Separately, Maxim Group set a $4.00 price objective on ContraVir Pharmaceuticals and gave the company a “buy” rating in a research report on Monday, October 30th.
A hedge fund recently raised its stake in ContraVir Pharmaceuticals stock. Vanguard Group Inc. lifted its position in shares of ContraVir Pharmaceuticals Inc (NASDAQ:CTRV) by 17.9% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 2,414,475 shares of the biopharmaceutical company’s stock after acquiring an additional 366,192 shares during the quarter. Vanguard Group Inc. owned approximately 3.79% of ContraVir Pharmaceuticals worth $1,400,000 at the end of the most recent reporting period. 6.65% of the stock is currently owned by institutional investors and hedge funds.
About ContraVir Pharmaceuticals
Receive News & Stock Ratings for ContraVir Pharmaceuticals Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ContraVir Pharmaceuticals Inc and related stocks with our FREE daily email newsletter.